FRBRX Mutual Fund

NAV$188.53

Returns Overview

1 Month
+3.25%
3 Months
+1.82%
6 Months
+42.15%
YTD
+4.12%
1 Year
+55.82%
3 Years
+28.39%
5 Years
+8.87%
10 Years
+15.09%

Risk Metrics (5-Year)

No risk data available for this ETF

Stress Test Scenarios

How would FRBRX have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

No data

3 Months Performance

No data

6 Months Performance

No data

1 Year Performance

No data

Benchmark & Peers

Benchmark
NASDAQ Biotechnology Index(^NBI)
This Mutual Fund (YTD)
+4.12%
Peer Avg (YTD)
+1.55%
vs Peers
+2.57%

FRBRX Mutual Fund Performance

FRBRX performance across multiple time periods: 1-month 3.25%, YTD 4.12%, 1-year 55.82%, 3-year 28.39%, 5-year 8.87%, 10-year 15.09%.

FRBRX returns outperform the peer average of 1.55% YTD. With an expense ratio of 0.67%, investors should weigh costs against performance when evaluating this mutual fund.

FRBRX performance comparison shows side-by-side returns with another fund. FRBRX alternatives are available in the Mutual Fund Screener.